Kujaza FDA kwa UniQure, Tiba ya Jeni ya Haemophilia B iliyopangwa mapema 2022

Kujaza FDA kwa UniQure, Tiba ya Jeni ya Haemophilia B iliyopangwa mapema 2022

KwanzaWord Pharma

Image

Please enable the javascript to submit this form

Inafadhiliwa na ruzuku za elimu kutoka Bayer, BioMarin, CSL Behring, Freeline Therapeutics Limited, Pfizer Inc., Spark Therapeutics, na uniQure, Inc.

SSL muhimu